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EXERCISE OR NEUROMUSCULAR ELECTRICAL 
STIMULATION: WHICH ONE IS MORE EFFECTIVE IN 
QUADRICEPS FAT MASS REDUCTION AND STRENGTH 
INCREASE IN OSTEOARTHRITIC KNEES? 
G Baltaci, V Bayrakci Tunay, E Yakut, N Vardar 
Physical Therapy and Rehabilitation, Hacettepe University, 
Ankara, Turkey 
Aims of Study: Patients with osteoarthritis (OA) have quadri- 
ceps weakness, pain in activity and quadriceps muscle inhibi- 
tion (QMI).The purpose of this study was to assess the effects 
of two different reatment programme on the quadriceps muscle 
fat mass and strength. 
Methods: Thirty-four females with bilateral knee OA (Altman 
Grade II) were divided into 2 random groups (GI to GII). The pa- 
tients in group I received pilates exercise (45 min) and group II 
received neuromuscular electrical stimulation (NMES) (30 min) 
5 times weekly for 4 weeks. The mean age and body mass in- 
dex (BMI) of the patients in GI were 504-6.21and 28.064-5.06 
and in GII were 53.264-8.9 and 28.524-5.13. Visual analogue 
scale (VAS) was used to measure knee pain intensity during ac- 
tivity. Symptoms were monitored by the "Western Ontario and 
McMaster Universities" (WOMAC) OA index. Fat thickness was 
measured with Skyndex System I (Caldwell, Justiss&Company, 
Inc,from quadriceps muscle belly. Quadriceps muscle strength 
was evaluated with Nicholas manuel muscle tester. All tests were 
done before and after treatment. 
Results: Statistically significant differences were found in all tests 
in GI before and after 4 weeks treatment evaluations (p<0.05), 
but in GII there was no statistically significant difference found 
in quadriceps strength (p>0.05). Quadriceps strength was in- 
creased %1 in GI (p<0.05) and % 0.5 in GII (p>0.05). Thigh fat 
thickness was decreased %1.12 in GI (p<0.05), % 0.46 in GII 
(P<0.05). 
Conclusions: Exercise programmes and physical therapy 
modalities that facilitate muscle activation like NMES are neces- 
sary to enhance the quadriceps trength and reduce fat mass in 
the patients with knee OA. But exercises are more effective in 
these improvements. 
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GLUCOSAMINE PLASMA AND SYNOVIAL FLUID 
CONCENTRATIONS BEFORE AND AFTER ORAL 
ADMINISTRATION OF CRYSTALLINE GLUCOSAMINE 
SULFATE IN KNEE OSTEOARTHRITIS PATIENTS 
S Persiani 1 , R Rotini 2, G Trisolino 2, LC Rovati 1 , M Locatelli 3, A 
Roda 3 
1Clinical Pharmacology Dept., Rottapharm, Monza, Mi, Italy; 
2 Codivilla Dept., Rizzofi Orthopaedic Institute, Bologna, Italy; 
3Dept. Pharmaceutical Sciences, University of Bologna, 
Bologna, Italy 
Aim of Study: The pharmacokinetics of glucosamine in plasma 
has been recently described after oral administration to healthy 
volunteers of crystalline glucosamine sulfate, i.e. the only glu- 
cosamine formulation shown to be a symptom- and structure- 
modifying drug in osteoarthritis. The aim of the present study was 
to assess glucosamine levels in plasma and synovial fluid before 
and after administration of crystalline glucosamine sulfate in ther- 
apeutic doses to patients with knee osteoarthritis. 
Methods: Five patients (3 men, 2 women) with knee osteoarthri- 
tis received oral crystalline glucosamine sulfate soluble powder 
1500 mg once-a-day (Rottapharm, Monza, Italy) for 14 consecu- 
tive days. Blood and synovial fluid samples were collected before 
the first drug administration and 3 hours after the last administra- 
tion, when steady state plasma concentrations were at maximum 
in the previous healthy volunteer study. Glucosamine concentra- 
tions were determined by a Liquid Chromatography with Mass 
Spectrometry detection (LC-MS/MS) method, with a quantitation 
limit of 2 ng/ml. 
Results: The mean (SE) age, height, weight and BMI of the 
enrolled patients were 534-5 years, 1714-6 cm, 804-7 kg and 
26.84-1.3 kg/cm 2, respectively. Endogenous glucosamine was 
detected in baseline plasma and synovial fluid samples, with 
mean (SE) concentrations of 39.54-5.1 ng/ml (0.24-0.03 I~M) and 
15.14-6.8 ng/ml (0.084-0.04 I~M), respectively. Three hours after 
the last glucosamine sulfate administration, baseline-subtracted 
concentrations were 14194-711 ng/ml (7.94-3.9 I~M) in plasma 
and 12914-576 ng/ml (7.24-3.2 I~M) in the synovial fluid. 
Conclusions: As in healthy volunteers, endogenous glu- 
cosamine is present in plasma of knee osteoarthritis patients and 
reaches concentrations in the 10 I~M range after repeated oral 
doses of crystalline glucosamine sulfate. We describe here for 
the first time that endogenous glucosamine is detectable also 
in the synovial fluid of knee osteoarthritis patients and that, af- 
ter repeated dosing, the plasma and synovial fluid concentra- 
tions achieved are similar. Glucosamine concentrations in the 
10 I~M range are effective in selected human chondrocyte mod- 
els. Nevertheless, further studies are needed to investigate glu- 
cosamine mechanism of action at these concentrations, as well 
as the pathophysiological relevance of different endogenous lev- 
els in osteoarthritis patients and the correlation between the lev- 
els achieved after exogenous administration and the treatment 
response. 
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EXTRACORPOREALSHOCK-WAVE THERAPY IMPROVE 
MOTOR DYSFUNCTION AND PAIN ORIGINATED FROM 
KNEE OSTEOARTHRITIS 
N Ochiai 1 , S Ohtori 1 , T Sasho ~ , R Murata ~ , H Moriya ~ , Y 
Wada 2, T Saisu 3 
1Dept of Orthopedic Surgery, Graduate School of Medicine, 
Chiba Universi~ Chiba City, Japan; 2Dept of Orthopaedic 
Surgery, Teikyo University Ichihara Hospital, Chiba City, Japan; 
3Div of Orthopedic Surgery, Chiba Children's Hosp., Chiba City, 
Japan 
Introduction: There have been several reports on the use of ex- 
tracorporeal shock waves (ESW) in the treatment of pseudarthro- 
sis, calcifying tendinitis, and tennis elbow. However, efficacy of 
ESW treatment for knee osteoarthritis (OA) has not been clari- 
fied. 
Purpose; To investigate the effect of ESW application for knee 
OA, we analyzed walking duration using treadmill and changes 
of calcitonin gene-related peptide (CGRP), which is a marker of 
inflammatory pain, in dorsal root ganglion (DRG) neurons in OA 
rats immunohistochemistry. 
Material and method: OA model: We transected anterior cruci- 
ate ligament, medial meniscus and medial collateral igament o 
make OA model, and evaluated 18 knee OA rats 6 months after 
surgery. 
Behavioral test: Six knee OA rats were used for behavioral anal- 
ysis. We measured walking duration before application of shock 
wave, on 2 days, 4 days, 7 days, 14 days, 21 days and 28 days af- 
ter ESW application, and these distances were statistically com- 
pared by non paired t-test. 
Immunohistochemistry: We used 3 groups. 1) Control group (6 
knees) 2) OA group (6 knees) 3) OA + ESW group (6 knees). 
Fuorogold (FG) (neurotracer) were injected into the medial knee 
joint to detect DRG neurons innervating knee in 3 groups. In the 
ESW group, shock wave (1000 shots, 4Hz, 0.08mJ/mm2: Dornier 
Epos) was applied into the medial knee joint 10 days after in- 
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jection of FG. All rats were perfused 14 days after application 
of FG. After fixation, DRGs from L1 to L6 were harvested, sec- 
tioned, and immunostained for CGRR The ratios of CGRP-ir FG- 
labeled neurons/FG-labelled neurons in 3 groups were compared 
by Mann-Whitney U-test. 
Result: Behavioral test: Walking duration on treadmill signifi- 
cantly extended in 2days, 4days, and 14days after application of 
ESW in OA rats (p<0.05). However, there was no significance in 
waking duration on 21 days and 28days compared with that before 
ESW application. ESW was effective until 14days. 
Immunohistochemistry: In 3 groups, FG-labeled dorsal root gan- 
glion neurons innervating the medial knee joint were distributed 
in the L1 to L6 dorsal root ganglia. There was no significant dif- 
ference in the distribution among 3 groups. Of FG labeled neu- 
rons, the ratios of CGRP-ir neurons in control and OA + ESW 
group were significantly less than that in OA group (control group 
(16.0%); OA group (36.2%); OA + ESW group(15.0%)) (p<0.05). 
ESW application reduced the ratio of CGRP-ir neurons in DRG of 
OA model. 
Discussion and conclusion: We previously reported that appli- 
cation of ESW to normal rat skin reduced the CGRP expression in 
DRG neurons and degeneration of free nerve endings. However, 
ESW was applied to the pathological model in the current study, 
and we confirmed the reduction of CGRP-ir neurons in DRG, and 
observed improvement in running ability. These data shows that 
ESW therapy may be useful for the treatment of knee OA. 
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DOES NEUROMUSCULAR ELECTRICAL STIMULATION 
IMPROVE STRENGTH AND PHYSICAL FUNCTION IN 
MIDDLE-AGED FEMALE PATIENTS WITH 
OSTEOARTHRITIS? 
V Bayrakci Tunay, G Baltaci, E Yakut, N Vardar 
Physiotherapy, Hacettepe Universi~ Ankara, Samanpazari, 
Turkey 
Aims of Study: The purpose of this study was to compare the 
effects of neuromuscular electrical stimulation (NMES) given in 
an individually attended treatment programme and compare re- 
sults with an isotonic based strengthening programme given in 
an group format on strength, function and health related quality 
of life in osteoarthritis (OA) of the knee. 
Methods: Patients were randomised into one of two groups: 
NMES (30 minute(n=17, mean age: 504-6.21 years) and exer- 
cise (n=17, mean age:53.264-8.9 years). They were taken to the 
treatment programme five times a week for four weeks, totally 
20 sessions. Quadriceps muscle strength with the dynamometer, 
10 meter walk test, time get up and go test, knee pain intensity 
during activity (visual analogue scale), "Western Ontario and Mc- 
Master Universities" (WOMAC) OA index and Health Assessment 
Questionaire (HAQ) 
Results: Clinically and statistically significant improvements were 
seen in all tests in both groups except quadriceps strength in 
NMES group. Quadriceps strength was increased % 0.5 in NMES 
(p>0.05), %1 in exercise (p<0.05). Time for ten meter walking 
time was improved %0.25 in NMES (p<0.05), %0.4 in exercise 
(p<0.05), time for time get up&go test was improved %0.4 in 
NMES (p<0.05), %0.2 in exercise (p<0.05), VAS score was de- 
creased %52.8 in NMES (p<0.05), %713.1 in exercise (p<0.05), 
WOMAC index score was improved %102.1 in NMES (p<0.05), 
%71.4 in exercise (p<0.05), HAQ score was improved %53.1 in 
NMES (p<0.05), %49.7 in exercise (p<0.05). 
Conclusions: Both in NMES and exercise group yields functional 
benefits for patients with OA of the knee. A combination of these 
two treatment groups may be more beneficial. 
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VASCULAR MECHANISMS IN OSTEOARTHRITIS: 
RATIONALE FOR TREATMENT WITH A MARINE-BASED 
COMPLEMENTARY MEDICINE 
PA Cheras, L Stevenson, SP Myers 
Australian Centre for Complementary Medicine Education and 
Research, University of Queensland and Southern Cross 
University, Brisbane, Queensland, Australia 
Aim: To undertake in vitro laboratory studies in Biolane Green 
Lipped Mussel Extract (GLME) to determine the levels of selected 
biological activities indicated by a vascular concept of osteoarthri- 
tis causation to be potentially useful in modifying disease progres- 
sion. 
Methods: The assays tested cholesterol synthesis inhibition, anti 
oxidant capacity and inhibition of the following components of 
the inflammatory pathways - tissue necrosis factor alpha (TNF- 
a), nuclear factor kB (NfkB), Cox-2 expression, prostaglandin E2 
(PGE2) and phospholipase A2 (PLA 2). Platelet aggregation in- 
hibitory activity was assessed with the agonists collagen and 
ADP and fibrinolytic activity was also assessed with the euglobu- 
lin clot lysis time (ECLT). An in vitro model based on gastric and 
duodenal secretions was used to simulate in vivo digestive pro- 
cesses. The digest prepared from the GLME samples contained 
the prominent gastric enzyme pepsin followed by pancreatic en- 
zymes. 
Results: Table 1 shows reduced anti-inflammatory activity as- 
sociated with GLME complete digest across a range of inflam- 
matory mediators though it is apparently not mediated through 
Cox-2 inhibition. Mild anti-oxidant activity is shown together with 
inhibition of platelet aggregation. Fibrinolytic activity is enhanced 
as shown by the reduced clot lysis time while cholesterol biosyn- 
thesis is inhibited by a level that would be clinically beneficial if it 
was translated to a clinical outcome. 
Table 1. Effect of GLME digests across a range of bioactivities that are 
potentially linked to OA pathomechanisms 
Test Resu It 
Anti-inflammatory activity 
TNFa 25% reduction 
Cox-2 0.4% reduction 
PGE2 45% reduction 
PLA2 27% reduction 
Anti-oxidant activity 
ORAC = 285mmol Vit E analogue/g sample 
Platelet aggregability 
Collagen 24% reduction 
ADP 18% reduction 
Fibrinolytic activity 
ECLT 15% reduction (= improved fibrinolysis) 
CHOL biosynthesis 8% reduction 
Conclusions: A vascular concept of OA causation predicts that 
a range of biological activities including anti-inflammatory, antico- 
agulant, lipolytic and fibrinolytic activity are potentially necessary 
in order to effectively break the web of pathology linking increased 
coagulation risk factors, decreased fibrinolytic activity and inflam- 
mation that drives the pathomechanisms associated with OA. Bi- 
olane Green Lipped Mussel Extract shows these in vitro biological 
activities in a laboratory system designed to mimic gastric and 
duodenal secretions. These findings are consistent with anec- 
dotal claims of symptomatic OA benefit in patients treated with 
GLME. 
